FDA Inspection 843597 — Aesculap Inc
The FDA completed an inspection of Aesculap Inc on August 9, 2013 in Hazelwood, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 9, 2013
- Fiscal Year
- 2013
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Hazelwood, MO (United States)